San Diego, CACIK 12326214 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
75 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Aurinia Pharmaceuticals Inc | 11.33M | $180.71M | 8.9% | 0 | Held |
| 2 | Galapagos NV | 3.92M | $128.22M | 6.3% | −230.0K | Reduced |
| 3 | Ptc Therapeutics Inc | 1.50M | $113.94M | 5.6% | 0 | Held |
| 4 | Celcuity Inc |
| 1.05M |
| $104.73M |
| 5.2% |
| −100.0K |
| Reduced |
| 5 | Mirum Pharmaceuticals Inc | 1.24M | $97.63M | 4.8% | 0 | Held |
| 6 | Tarsus Pharmaceuticals Inc | 1.19M | $97.32M | 4.8% | −1.27M | Reduced |
| 7 | Kiniksa Pharmaceuticals Intl | 2.26M | $93.22M | 4.6% | −68.7K | Reduced |
| 8 | Immunocore Hldgs PLC | 2.63M | $91.24M | 4.5% | +322.9K | Added |
| 9 | Compass Therapeutics Inc | 16.79M | $90.17M | 4.5% | −21.2K | Reduced |
| 10 | Kalvista Pharmaceuticals Inc | 4.57M | $73.86M | 3.6% | −468.3K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio